FDA Approved: HEPARIN SODIUM — Supplemental Application (Civica, Inc.)

View source ↗

Summary

The FDA approved Civica, Inc.'s supplemental application for Heparin Sodium. This action updates the product labeling as part of the NDA 017037 supplemental app…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Deep Vein Thrombosis
• Myocardial Infarction
• Pulmonary Embolism

Drugs mentioned

• HEPARIN SODIUM (HEPARIN SODIUM)

Snippet

SUPPL AP for HEPARIN SODIUM (HEPARIN SODIUM)